Framingham Stroke Risk Profile and poor cognitive function: a population-based study.
Llewellyn, DJ; Lang, IA; Xie, J; et al.Huppert, FA; Melzer, D; Langa, KM
Date: 22 April 2008
BACKGROUND: The relationship between stroke risk and cognitive function has not previously been examined in a large community living sample other than the Framingham cohort. The objective of this study was to examine the relationship between 10-year risk for incident stroke and cognitive function in a large population-based sample. ...
BACKGROUND: The relationship between stroke risk and cognitive function has not previously been examined in a large community living sample other than the Framingham cohort. The objective of this study was to examine the relationship between 10-year risk for incident stroke and cognitive function in a large population-based sample. METHODS: Participants were 7377 adults aged 50 years and over of the 2002 wave of the English Longitudinal Study of Ageing, a prospective cohort study. A modified version of the Framingham Stroke Risk Profile (incorporating age, sex, systolic blood pressure, antihypertensive medication, diabetes, smoking status, cardiovascular disease, and atrial fibrillation) was used to assess 10-year risk of stroke. Linear regression models were used to determine the cross-sectional relationship of stroke risk to global cognitive function and performance in multiple cognitive domains. RESULTS: In unadjusted models 10 percentage point increments of 10-year stroke risk were associated with poor global cognitive function (-0.40 SD units, 95% CI -0.43 - -0.38), and lowered performance in all cognitive domains. After statistical adjustment for age, sex, testing interval and other correlates of cognitive function the association with stroke risk was attenuated though remained significant for global cognitive function (-0.06 SD units, 95% CI -0.09 - -0.03), immediate and delayed verbal memory, semantic verbal fluency and processing speed. CONCLUSION: In individuals free from a history of stroke or dementia, high subclinical cerebrovascular disease burden was associated with worse cognitive function in multiple domains.
Institute of Biomedical & Clinical Science
College of Medicine and Health
Item views 0
Full item downloads 0
Showing items related by title, author, creator and subject.
Epigenetic studies in Alzheimer's disease: Current findings, caveats, and considerations for future studies Lunnon, Katie; Mill, J (Wiley, 13 September 2013)Alzheimer's disease (AD) is a sporadic, chronic neurodegenerative disease, usually occurring late in life. The last decade has witnessed tremendous advances in our understanding about the genetic basis of AD, but a large ...
Improving the experience of dementia and enhancing active life--living well with dementia: study protocol for the IDEAL study. Clare, L; Nelis, SM; Quinn, C; et al. (BioMed Central, 30 November 2014)BACKGROUND: Enabling people with dementia and carers to 'live well' with the condition is a key United Kingdom policy objective. The aim of this project is to identify what helps people to live well or makes it difficult ...
Plain packaging of cigarettes and smoking behavior: study protocol for a randomized controlled study. Maynard, OM; Leonards, U; Attwood, AS; et al. (BioMed Central, 25 June 2014)BACKGROUND: Previous research on the effects of plain packaging has largely relied on self-report measures. Here we describe the protocol of a randomized controlled trial investigating the effect of the plain packaging of ...